First Trust Bank Ltd. purchased a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,446 shares of the semiconductor company’s stock, valued at approximately $4,659,647,000. Synopsys makes up about 9.4% of First Trust Bank Ltd.’s portfolio, making the stock its 5th largest holding.
A number of other large investors have also modified their holdings of the stock. Sankala Group LLC acquired a new stake in shares of Synopsys in the fourth quarter valued at $25,000. Elevation Wealth Partners LLC grew its stake in Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares in the last quarter. IMG Wealth Management Inc. acquired a new position in Synopsys during the 2nd quarter worth $28,000. Caitong International Asset Management Co. Ltd purchased a new stake in Synopsys during the 4th quarter worth about $28,000. Finally, Atlas Capital Advisors Inc. acquired a new stake in Synopsys in the 4th quarter valued at about $32,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Trading Down 0.0%
NASDAQ:SNPS opened at $397.87 on Friday. Synopsys, Inc. has a 1 year low of $366.00 and a 1 year high of $615.79. The stock has a market cap of $76.18 billion, a P/E ratio of 92.10, a P/E/G ratio of 2.34 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The stock has a 50-day simple moving average of $419.73 and a 200-day simple moving average of $440.22.
Insider Buying and Selling
In related news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This trade represents a 16.29% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. This represents a 19.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
SNPS has been the subject of several recent research reports. Piper Sandler upgraded Synopsys from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. Berenberg Bank set a $633.00 target price on shares of Synopsys in a report on Wednesday, May 27th. BNP Paribas Exane boosted their price target on shares of Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a report on Thursday, May 28th. Finally, Robert W. Baird set a $558.00 price objective on shares of Synopsys in a research report on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $563.59.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
- Five stocks we like better than Synopsys
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
